Scarica l'app Stockscreener
9.73
2.11%
-0.21
Dopo l'orario di chiusura:
9.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Precedente Chiudi:
$9.94
Aprire:
$9.92
Volume 24 ore:
393.15K
Relative Volume:
0.64
Capitalizzazione di mercato:
$523.77M
Reddito:
$217.25M
Utile/perdita netta:
$-50.92M
Rapporto P/E:
-9.73
EPS:
-1
Flusso di cassa netto:
$-100.85M
1 W Prestazione:
+5.19%
1M Prestazione:
+1.99%
6M Prestazione:
+45.66%
1 anno Prestazione:
-39.34%
Intervallo 1D:
$9.68
$10.09
Intervallo di 1 settimana:
$9.24
$10.53
Portata 52W:
$4.32
$16.66
Prothena Corporation Plc Stock (PRTA) Company Profile
Nome
Prothena Corporation Plc
Settore
Industria
Telefono
011-353-1-236-2500
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Confronta PRTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
9.73 | 535.07M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-27 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-01-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-04-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-27 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-06-18 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Reiterato | Oppenheimer | Outperform |
| 2021-05-26 | Iniziato | Citigroup | Buy |
| 2021-02-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-07 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Downgrade | Jefferies | Buy → Hold |
| 2018-04-05 | Reiterato | Barclays | Overweight |
| 2017-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2017-09-29 | Reiterato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Jefferies | Buy |
| 2017-04-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2017-03-02 | Iniziato | Instinet | Buy |
| 2016-12-21 | Iniziato | SunTrust | Buy |
| 2016-11-03 | Iniziato | Deutsche Bank | Buy |
| 2016-08-04 | Reiterato | Barclays | Overweight |
| 2016-05-13 | Iniziato | Barclays | Overweight |
| 2016-02-19 | Reiterato | Wedbush | Outperform |
| 2016-01-21 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
Prothena (NASDAQ:PRTA) Share Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Can Calidi Biotherapeutics Inc reach resistance levels soonWeekly Stock Summary & Community Trade Idea Sharing - baoquankhu1.vn
Trading Systems Reacting to (PRTA) Volatility - Stock Traders Daily
Prothena Corporation Plc (PRTA) Stock Analysis: Evaluating A Potential 96.65% Upside - DirectorsTalk Interviews
Will Prothena Corporation plc benefit from rising consumer demand2025 Market Outlook & Daily Profit Focused Stock Screening - mfd.ru
All You Need to Know About Prothena (PRTA) Rating Upgrade to Buy - Yahoo Finance
Aug Sectors: Will Prothena Corporation plc outperform tech stocks2025 EndofYear Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
Recap Report: Will Melar Acquisition Corp I announce a stock split2025 Price Momentum & Precise Entry and Exit Recommendations - baoquankhu1.vn
Prothena Corporation plc (NASDAQ:PRTA) Sees Significant Growth in Short Interest - MarketBeat
Prothena Corp (PRTA) Analyst Ratings: RBC Capital's New Price Ta - GuruFocus
Prothena announces board of directors update - MSN
How Prothena Corporation Plc (PRTA) Affects Rotational Strategy Timing - Stock Traders Daily
Value Recap: What Wall Street predicts for Prothena Corporation plc stock price2025 Pullback Review & Consistent Income Trade Recommendations - Bộ Nội Vụ
Prothena Corporation plc (NASDAQ:PRTA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Can Prothena Corporation plc stock sustain revenue growthJuly 2025 PostEarnings & Entry Point Strategy Guides - Улправда
Why hedge funds are buying Prothena Corporation plc stockDay Trade & Daily Entry Point Trade Alerts - Улправда
How Are Partnered Pipelines Rewriting The Prothena (PRTA) Narrative And Price Target Outlook - Yahoo Finance UK
Macro Review: What valuation multiples suggest for Prothena Corporation plc stockWeekly Profit Summary & Long Hold Capital Preservation Plans - Bộ Nội Vụ
We Think Prothena (NASDAQ:PRTA) Can Afford To Drive Business Growth - Yahoo Finance
(PRTA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
89,704 Shares in Prothena Corporation plc $PRTA Acquired by Assenagon Asset Management S.A. - Defense World
(PRTA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Prothena Corporation plc(NasdaqGS:PRTA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Squarepoint Ops LLC Takes $1.27 Million Position in Prothena Corporation plc $PRTA - Defense World
Earnings Miss: Why Prothena Corporation plc stock remains undervaluedStock Surge & Fast Entry Momentum Trade Alerts - Улправда
Why Prothena Corporation plc stock remains undervaluedDip Buying & Free High Return Stock Watch Alerts - Улправда
What catalysts could drive Prothena Corporation plc stock higherDip Buying & AI Based Trade Execution Alerts - DonanımHaber
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Birchview Capital LP Has $2.74 Million Stock Holdings in Prothena Corporation plc $PRTA - MarketBeat
Prothena Board Member Paula Cobb Resigns - The Globe and Mail
Paula Cobb steps down from Prothena’s board to join Manifold Bio - Investing.com Nigeria
Paula Cobb steps down from Prothena’s board to join Manifold Bio By Investing.com - Investing.com South Africa
[8-K] PROTHENA CORP PUBLIC LTD CO Reports Material Event | PRTA SEC FilingForm 8-K - Stock Titan
Prothena Announces Board of Directors Update - Yahoo Finance
What analysts say about Prothena Corporation plc stockMean Reversion Trades & Free Harness Proven Investment Plans - earlytimes.in
Prothena Corporation plc $PRTA Shares Bought by Federated Hermes Inc. - MarketBeat
Liquidity Mapping Around (PRTA) Price Events - Stock Traders Daily
Prothena (PRTA) price target increased by 10.91% to 20.74 - MSN
Ready to Jump After Recent Trade: Prothena Corporation plc (PRTA) - setenews.com
How the Narrative Surrounding Prothena Is Changing After New Pipeline and Valuation Updates - Yahoo Finance
Prothena (PRTA) Price Target Increased by 10.91% to 20.74 - Nasdaq
Will Prothena Corporation plc stock outperform international peersTrade Entry Summary & Breakout Confirmation Trade Signals - Newser
Prothena (NASDAQ:PRTA) Stock Price Up 7.4%Here's Why - MarketBeat
Are Smart Investors Making the Right Decision? Prothena Corporation plc (PRTA) - setenews.com
Prothena Corp (PRTA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Citizens Jmp Forecasts Strong Price Appreciation for Prothena (NASDAQ:PRTA) Stock - MarketBeat
Prothena (NASDAQ:PRTA) Price Target Raised to $19.00 at Citizens Jmp - Defense World
Prothena stock price target raised to $19 from $11 at Citizens - Investing.com Nigeria
Prothena stock price target raised to $19 from $11 at Citizens By Investing.com - Investing.com South Africa
Citizens Raises Price Target for Prothena Corp (PRTA) to $19.00 - GuruFocus
Prothena Corporation plc Stock Analysis and ForecastFundamental Stock Analysis & Double Digit Portfolio Growth - earlytimes.in
Prothena Corporation Plc Azioni (PRTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Prothena Corporation Plc Azioni (PRTA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):